Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AMLX |
---|---|---|
09:32 ET | 1496 | 2.28 |
09:34 ET | 800 | 2.26 |
09:36 ET | 881 | 2.252 |
09:41 ET | 400 | 2.26 |
09:50 ET | 790 | 2.24 |
09:54 ET | 100 | 2.24 |
09:56 ET | 100 | 2.235 |
09:57 ET | 1457 | 2.2208 |
10:01 ET | 3158 | 2.24 |
10:03 ET | 779 | 2.245 |
10:06 ET | 2342 | 2.24 |
10:10 ET | 6306 | 2.225 |
10:12 ET | 100 | 2.225 |
10:14 ET | 1100 | 2.23 |
10:15 ET | 1500 | 2.235 |
10:17 ET | 300 | 2.235 |
10:24 ET | 100 | 2.235 |
10:26 ET | 100 | 2.235 |
10:28 ET | 301 | 2.2308 |
10:32 ET | 1670 | 2.23 |
10:33 ET | 100 | 2.225 |
10:39 ET | 348 | 2.225 |
10:42 ET | 4300 | 2.225 |
10:44 ET | 100 | 2.225 |
10:46 ET | 900 | 2.235 |
10:48 ET | 2600 | 2.235 |
10:50 ET | 2604 | 2.225 |
10:53 ET | 258 | 2.225 |
10:57 ET | 300 | 2.225 |
11:00 ET | 200 | 2.225 |
11:02 ET | 375 | 2.2247 |
11:04 ET | 500 | 2.2248 |
11:06 ET | 956 | 2.2201 |
11:08 ET | 2663 | 2.21 |
11:09 ET | 695 | 2.2107 |
11:11 ET | 6451 | 2.205 |
11:13 ET | 2263 | 2.21 |
11:15 ET | 100 | 2.205 |
11:18 ET | 593 | 2.21 |
11:20 ET | 300 | 2.205 |
11:22 ET | 3119 | 2.205 |
11:24 ET | 1400 | 2.205 |
11:26 ET | 2100 | 2.2041 |
11:27 ET | 10498 | 2.195 |
11:29 ET | 500 | 2.195 |
11:31 ET | 500 | 2.1997 |
11:33 ET | 3427 | 2.195 |
11:36 ET | 500 | 2.195 |
11:38 ET | 400 | 2.195 |
11:40 ET | 1248 | 2.195 |
11:42 ET | 2957 | 2.18 |
11:44 ET | 2801 | 2.185 |
11:45 ET | 4892 | 2.185 |
11:47 ET | 2845 | 2.185 |
11:49 ET | 4054 | 2.175 |
11:51 ET | 3021 | 2.1708 |
11:54 ET | 370 | 2.175 |
11:56 ET | 585 | 2.175 |
11:58 ET | 11416 | 2.19 |
12:00 ET | 26630 | 2.195 |
12:02 ET | 600 | 2.195 |
12:03 ET | 200 | 2.195 |
12:05 ET | 450 | 2.195 |
12:07 ET | 600 | 2.19 |
12:09 ET | 466 | 2.19 |
12:12 ET | 1430 | 2.2 |
12:14 ET | 300 | 2.205 |
12:18 ET | 5785 | 2.22 |
12:20 ET | 1700 | 2.2108 |
12:21 ET | 4520 | 2.2145 |
12:25 ET | 300 | 2.215 |
12:27 ET | 4394 | 2.2275 |
12:32 ET | 1000 | 2.24 |
12:36 ET | 2041 | 2.245 |
12:38 ET | 1100 | 2.245 |
12:41 ET | 3227 | 2.244 |
12:43 ET | 1530 | 2.255 |
12:50 ET | 100 | 2.255 |
12:52 ET | 17852 | 2.245 |
12:54 ET | 13526 | 2.225 |
12:56 ET | 600 | 2.225 |
12:57 ET | 100 | 2.22 |
12:59 ET | 1625 | 2.22 |
01:01 ET | 100 | 2.22 |
01:03 ET | 100 | 2.225 |
01:06 ET | 12487 | 2.22 |
01:10 ET | 12084 | 2.24 |
01:14 ET | 15840 | 2.235 |
01:15 ET | 1161 | 2.235 |
01:17 ET | 827 | 2.235 |
01:19 ET | 4001 | 2.24 |
01:21 ET | 600 | 2.24 |
01:24 ET | 400 | 2.24 |
01:26 ET | 200 | 2.24 |
01:30 ET | 7455 | 2.245 |
01:32 ET | 400 | 2.245 |
01:33 ET | 1763 | 2.235 |
01:37 ET | 977 | 2.235 |
01:42 ET | 100 | 2.24 |
01:44 ET | 200 | 2.24 |
01:48 ET | 142 | 2.235 |
01:50 ET | 650 | 2.235 |
01:51 ET | 900 | 2.2301 |
01:53 ET | 2068 | 2.225 |
01:55 ET | 300 | 2.2208 |
02:02 ET | 200 | 2.22 |
02:04 ET | 100 | 2.22 |
02:06 ET | 3570 | 2.215 |
02:08 ET | 200 | 2.215 |
02:09 ET | 2200 | 2.2101 |
02:11 ET | 169 | 2.215 |
02:13 ET | 100 | 2.21 |
02:18 ET | 600 | 2.22 |
02:20 ET | 300 | 2.215 |
02:22 ET | 100 | 2.22 |
02:24 ET | 200 | 2.21 |
02:26 ET | 200 | 2.215 |
02:27 ET | 200 | 2.215 |
02:29 ET | 100 | 2.21 |
02:33 ET | 5511 | 2.225 |
02:36 ET | 100 | 2.22 |
02:38 ET | 700 | 2.225 |
02:42 ET | 200 | 2.22 |
02:45 ET | 200 | 2.225 |
02:49 ET | 250 | 2.23 |
02:51 ET | 100 | 2.225 |
02:54 ET | 12701 | 2.215 |
02:56 ET | 300 | 2.21 |
02:58 ET | 200 | 2.21 |
03:00 ET | 4276 | 2.205 |
03:02 ET | 969 | 2.205 |
03:03 ET | 400 | 2.2092 |
03:07 ET | 100 | 2.205 |
03:09 ET | 100 | 2.21 |
03:12 ET | 100 | 2.2 |
03:14 ET | 300 | 2.205 |
03:16 ET | 8124 | 2.215 |
03:18 ET | 4924 | 2.225 |
03:20 ET | 8304 | 2.22 |
03:23 ET | 981 | 2.215 |
03:25 ET | 6123 | 2.2 |
03:27 ET | 3200 | 2.2 |
03:30 ET | 9936 | 2.215 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Amylyx Pharmaceuticals Inc | 153.9M | -0.9x | --- |
Organogenesis Holdings Inc | 375.2M | -22.3x | --- |
Amarin Corporation PLC | 266.2M | -7.5x | --- |
Coherus BioSciences Inc | 154.4M | -3.4x | --- |
Sinovac Biotech Ltd | 639.9M | -4.9x | --- |
Puma Biotechnology Inc | 132.4M | 13.6x | --- |
Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate: AMX0035 for the treatment of Wolfram syndrome and for the treatment of progressive supranuclear palsy, and AMX0114, the Company’s antisense oligonucleotide targeting calpain-2 for the treatment of amyotrophic lateral sclerosis (ALS). AMX0035 is a dual-unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). The Company’s Avexitide is an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist that has been evaluated in five clinical trials for post-bariatric hypoglycemia (PBH) and has also been studied in congenital hyperinsulinism (HI), two indications characterized by hyperinsulinemic hypoglycemia.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $153.9M |
---|---|
Revenue (TTM) | $298.8M |
Shares Outstanding | 68.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.45 |
Book Value | $6.40 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | 0.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -59.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.